Seres therapeutics to participate in cantor 2024 global healthcare conference

Cambridge, mass., sept. 13, 2024 (globe newswire) -- seres therapeutics, inc. (nasdaq: mcrb), a leading live biotherapeutics company, today announced that the company, will participate in the cantor global healthcare conference and eric shaff, president and chief executive officer, will represent seres in a presentation on september 18, 2024 at 3:05 p.m. et.
mcrb Ratings Summary
mcrb Quant Ranking